Neudreamer

We are a US-registered company specializing in neuromodulation, focused on the early prevention and treatment of Alzheimer's Disease (AD), Major Depressive Disorder (MDD), Insomnia, and other Neurology Diseases. Our globally patented technology, Rhythmic Deep Brain Low-Field Transcranial Magnetic Stimulation (rDMS), is integrated into a mature product. We utilize a closed-loop intervention to help our users sleep better. Combined with our sleep monitoring pad, this innovative approach is designed to maximize stimulation in memory consolidation and AD prevention, with promising results already observed. We are currently in the Phase 2A clinical trial stage and are seeking further collaborative research opportunities globally, especially in North America.